The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) has become a major health problem in developed countries. It has affected more than 30% of the general population and is commonly associated with insulin resistance, which is a major risk factor for the development of type 2 diabetes and a central feature of the metabolic syndrome. Furthermore, accumulating evidences reveal that NAFLD as well as insulin resistance is strongly related to inflammation. Cytokines and adipokines play a pivotal role in inflammatory processes. In addition, these inflammatory mediators regulate various functions including metabolic energy balance, inflammation, and immune response. However, their role in modulating ectopic lipids involved in the development of insulin resistance, such as diacylglycerols and ceramides, remains unknown. The aim of this review is first to describe the pathophysiology of insulin resistance in NAFLD. In particular, we discuss the role of ectopic lipid accumulation in the liver. Secondly, we also summarize recent findings emphasizing the role of main inflammatory markers in both NAFLD and insulin resistance and their potential role in modulating hepatic fat content in NAFLD and associated hepatic insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · cited 1×
“…at 11/13/2022 06:12:33PM via free access Jo u rn a l o f E n d o cr in o lo g y with obesity, insulin resistance, hypertension, and dyslipidemia, suggesting that NAFLD might be considered as the liver manifestation of the metabolic syndrome (Marchesini et al. 2001, Adams et al. 2005).”
BackgroundInflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · cited 1×
“However, recent findings unveiled this concept and described white adipose tissue as an active endocrine organ capable of synthesizing and secreting a multitude of hormones, cytokines, chemokines, and enzymes collectively known as adipokines (Halberg et al. 2008, Lumeng & Saltiel 2011).”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 1×
“Consistently, it was shown that TNFa or TNFa receptor knockout obese mice exhibit improved insulin sensitivity compared with wild-type obese mice (Uysal et al. 1997).”
BackgroundCause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M., Graubard, B. I., Williamson, D. F., & Gail, M. H. (2007) · JAMA · doi:10.1001/jama.298.17.2028 · Cited by 1,542 · cited 1×
“As mentioned earlier, obesity is now recognized as a chronic inflammatory disease that contributes to the development of various pathologies including cardiovascular diseases, type 2 diabetes, and NAFLD (Colicchio et al. 2005, Flegal et al. 2007, Freedman 2011, Tarantino &Caputi 2011).”
BackgroundLiver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 1×
“Preliminary studies found that IL6 plays a protective role in liver fibrosis by promoting hepatocyte proliferation and by protecting against oxidative stress and mitochondrial dysfunction (Cressman et al. 1996, El-Assal et al. 2004).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“Because of the major role of FA in the development of NAFLD, several strategies have targeted lipid synthesis to reduce hepatic steatosis (An et al. 2004, Samuel et al. 2004, Savage et al. 2006).”
BackgroundBoden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 1×
“On the other hand, mice lacking IL6 develop insulin resistance and mature onset obesity (Wallenius et al. 2002), which are major risk factors for the development of NAFLD.”
BackgroundInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1×
“1; Petersen & Shulman 2006, Schenk et al. 2008).”
Background(1966) · Index to Reviews, Symposia Volumes and Monographs in Organic Chemistry · doi:10.1016/b978-0-08-012210-6.50017-x · Cited by 1,190
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 1×
“Notably, in patients with type 2 diabetes and NAFLD, Petersen et al. have shown that moderate weight reduction (about 8 kg) was sufficient to improve NAFLD and reverse hepatic insulin resistance (Petersen et al. 2005).”
BackgroundInsulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875 · cited 1×
“This pathological accumulation of FA has been associated with lipotoxicity and insulin resistance (Unger 2002).”
BackgroundAdiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846 · cited 1×
“As IL6 induces a plethora of effects including insulin resistance and regulation of inflammation, known to be risk factors for NAFLD, it has been proposed as a potential mediator leading to NAFLD (Kishimoto 2010).”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“1; Petersen & Shulman 2006, Schenk et al. 2008).”
BackgroundAdiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., & Tilg, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.145 · Cited by 819
Bruun, J. M., Lihn, A. S., Verdich, C., Pedersen, S. B., Toubro, S., Astrup, A., & Richelsen, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2003 · Cited by 775
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 1×
“…susceptibility to develop the disease (Gariani et al. 2013), it appears that promoting factors notably include i) lipid intermediate accumulation, ii) altered expression of pro-inflammatory cytokines, and iii) mitochondrial dysfunction (Day & James 1998, Diehl et al. 2005, Begriche et al. 2006).”
BackgroundTissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Inflammatory pathways and insulin action
Hotamisligil, G. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802502 · Cited by 717
Ayala, J. E., Samuel, V. T., Morton, G. J., Obici, S., Croniger, C. M., Shulman, G. I., Wasserman, D. H., & McGuinness, O. P. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006239 · Cited by 716
Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Yecies, J. L., Zhang, H. H., Menon, S., Liu, S., Yecies, D., Lipovsky, A. I., Gorgun, C., Kwiatkowski, D. J., Hotamisligil, G. S., Lee, C.-H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.002 · Cited by 657
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis
Odegaard, J. I., & Chawla, A. (2013) · Science · doi:10.1126/science.1230721 · Cited by 643
Bastard, J.-P., Maachi, M., van Nhieu, J. T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.-J., Capeau, J., & Hainque, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8450 · Cited by 625
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127953.98131.ed · Cited by 555
Lang, C. H., Dobrescu, C., & Bagby, G. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727716 · Cited by 535
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., & Taylor, R. (1996) · Diabetes · doi:10.2337/diab.45.7.881 · Cited by 510
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 471
Das, K., Das, K., Mukherjee, P. S., Ghosh, A., Ghosh, S., Mridha, A. R., Dhibar, T., Bhattacharya, B., Bhattacharya, D., Manna, B., et al. (2010) · Hepatology · doi:10.1002/hep.23567 · Cited by 469
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447 · cited 1×
“Because of the major role of FA in the development of NAFLD, several strategies have targeted lipid synthesis to reduce hepatic steatosis (An et al. 2004, Samuel et al. 2004, Savage et al. 2006).”
BackgroundThe Adipocyte as an Endocrine Cell
Halberg, N., Wernstedt-Asterholm, I., & Scherer, P. E. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.002 · Cited by 442
Tanti, J.-F., & Jager, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.004 · Cited by 430
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
ARNER, P. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00024-9 · Cited by 423
Association between adiponectin and mediators of inflammation in obese women
Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Möhlig, M., Pfeiffer, A. F. H., Luft, F. C., & Sharma, A. M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.942 · Cited by 422 · cited 1×
“For instance, it has been shown that adiponectin plasma levels are inversely associated with IL6 and TNFa (Bruun et al. 2003, Engeli et al. 2003, Kern et al. 2003).”
BackgroundCeramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
Amarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., Shoelson, S. E., & for the TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00004 · Cited by 388
Apovian, C. M., Bigornia, S., Mott, M., Meyers, M. R., Ulloor, J., Gagua, M., McDonnell, M., Hess, D., Joseph, L., & Gokce, N. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.170316 · Cited by 386
Choi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X., Liu, Z.-X., Morino, K., Kim, S., Distefano, A., Samuel, V. T., Neschen, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704213200 · Cited by 383
Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., & Entman, M. L. (1999) · Circulation · doi:10.1161/01.cir.99.4.546 · Cited by 342
Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., & Yki–Järvinen, H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.021 · Cited by 339
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Hoehn, K. L., Hohnen-Behrens, C., Cederberg, A., Wu, L. E., Turner, N., Yuasa, T., Ebina, Y., & James, D. E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.005 · Cited by 320
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
Self-citationYu, X. X., Murray, S. F., Pandey, S. K., Booten, S. L., Bao, D., Song, X., Kelly, S., Chen, S., McKay, R., Monia, B. P., et al. (2005) · Hepatology · doi:10.1002/hep.20783 · Cited by 301
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
Rodriguez, A., Durán, A., Selloum, M., Champy, M.-F., Diez-Guerra, F. J., Flores, J. M., Serrano, M., Auwerx, J., Diaz-Meco, M. T., & Moscat, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.011 · Cited by 290 · cited 1×
“In line with these findings, others found that mice deficient in the signaling adapter p62, an ERK inhibitor protein, develop obesity and insulin resistance associated with enhanced basal level of ERK activity (Rodriguez et al. 2006).”
ResultHepatic triglyceride synthesis and nonalcoholic fatty liver disease
Choi, S. S., & Diehl, A. M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ff5e55 · Cited by 255
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Tilg, H. (2010) · Digestive Diseases · doi:10.1159/000282083 · Cited by 227
Carpentier, A., Mittelman, S. D., Bergman, R. N., Giacca, A., & Lewis, G. F. (2000) · Diabetes · doi:10.2337/diabetes.49.3.399 · Cited by 226
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 225
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
Diehl, A. M., Li, Z. P., Lin, H. Z., & Yang, S. Q. (2005) · Gut · doi:10.1136/gut.2003.024935 · Cited by 216
Birkenfeld, A. L., Lee, H.-Y., Guebre-Egziabher, F., Alves, T. C., Jurczak, M. J., Jornayvaz, F. R., Zhang, D., Hsiao, J. J., Martin-Montalvo, A., Fischer-Rosinsky, A., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.009 · Cited by 215
Self-citationJornayvaz, F. R., Jurczak, M. J., Lee, H.-Y., Birkenfeld, A. L., Frederick, D. W., Zhang, D., Zhang, X.-M., Samuel, V. T., & Shulman, G. I. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2010 · Cited by 211
Self-citationBandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210 · cited 2×
“In line with these results, several studies investigating the mechanisms of insulin resistance have reported that any defects in the IRS gene contribute to insulin resistance, therefore identifying IRS as amajor target in this disorder (Bandyopadhyay et al. 2005, Hoehn et al. 2008).”
BackgroundResultEffect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss
Jung, S. H., Park, H. S., Kim, K.-S., Choi, W. H., Ahn, C. W., Kim, B. T., Kim, S. M., Lee, S. Y., Ahn, S. M., Kim, Y. K., et al. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.05.007 · Cited by 199
Camporez, J. P. G., Jornayvaz, F. R., Lee, H.-Y., Kanda, S., Guigni, B. A., Kahn, M., Samuel, V. T., Carvalho, C. R. O., Petersen, K. F., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1989 · Cited by 192
Self-citationXu, H., Uysal, K. T., Becherer, J. D., Arner, P., & Hotamisligil, G. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1876 · Cited by 189
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Cintra, D. E., Pauli, J. R., Araújo, E. P., Moraes, J. C., de Souza, C. T., Milanski, M., Morari, J., Gambero, A., Saad, M. J., & Velloso, L. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.017 · Cited by 182
Free fatty acids impair hepatic insulin extraction in vivo.
Wiesenthal, S. R., Sandhu, H., McCall, R. H., Tchipashvili, V, Yoshii, H., Polonsky, K., Shi, Z. Q., Lewis, G. F., Mari, A., & Giacca, A. (1999) · Diabetes · doi:10.2337/diabetes.48.4.766 · Cited by 171
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Jornayvaz, F. R., Birkenfeld, A. L., Jurczak, M. J., Kanda, S., Guigni, B. A., Jiang, D. C., Zhang, D., Lee, H.-Y., Samuel, V. T., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103451108 · Cited by 164
Self-citationmTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis
Laplante, M., & Sabatini, D. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000323107 · Cited by 162
Cantley, J. L., Yoshimura, T., Camporez, J. P. G., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre-Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 161
Self-citationJurczak, M. J., Lee, A., Jornayvaz, F. R., Lee, H., Birkenfeld, A. L., Guigni, B. A., Kahn, M., Samuel, V. T., Glimcher, L. H., & Shulman, G. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316760 · Cited by 153
Self-citationEl-Assal, O. N., Hong, F., Kim, W., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 148
JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease
Tarantino, G., & Caputi, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i33.3785 · Cited by 144
Yamaguchi, K., Itoh, Y., Yokomizo, C., Nishimura, T., Niimi, T., Fujii, H., Okanoue, T., & Yoshikawa, T. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.75 · Cited by 143
Lee, H., Birkenfeld, A. L., Jornayvaz, F. R., Jurczak, M. J., Kanda, S., Popov, V., Frederick, D. W., Zhang, D., Guigni, B. A., Bharadwaj, K. G., et al. (2011) · Hepatology · doi:10.1002/hep.24571 · Cited by 136
Self-citationSignalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127 · cited 1×
“These proteins in turn phosphorylate IRS and the insulin receptor, leading to inhibition of insulin signaling (Weickert & Pfeiffer 2006).”
BackgroundFatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg, J., Strömblad, G., Wirth, A. G., Smith, U., & Björntorp, P. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115534 · Cited by 121
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 121
Self-citationObesity - United States, 1988-2008.
Freedman, D. S. (2011) · PubMed · Cited by 109
Non-Alcoholic Fatty Liver Disease in Young Adult Severely Obese Non-Diabetic Patients in South Italy
Colicchio, P., Tarantino, G., del Genio, F., Sorrentino, P., Saldalamacchia, G., Finelli, C., Conca, P., Contaldo, F., & Pasanisi, F. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000087295 · Cited by 103
Cleasby, M. E., Reinten, T. A., Cooney, G. J., James, D. E., & Kraegen, E. W. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0154 · Cited by 101
den Boer, M. A. M., Voshol, P. J., der Elst, J. P. S.-V., Korsheninnikova, E., Ouwens, D. M., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0417 · Cited by 95
Adiponectin: Key Player in the Adipose Tissue-Liver Crosstalk
Moschen, A. R., Wieser, V. E., & Tilg, H. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803833254 · Cited by 95
Jornayvaz, F. R., Lee, H., Jurczak, M. J., Alves, T. C., Guebre‐Egziabher, F., Guigni, B. A., Zhang, D., Samuel, V. T., Silva, J. E., & Shulman, G. I. (2011) · Endocrinology · doi:10.1210/en.2011-1793 · Cited by 85
Self-citationLee, Y.-M., Sutedja, D. S., Wai, C. T., Dan, Y.-Y., Aung, M., Zhou, L., Cheng, C. L., Wee, A., & Lim, S. G. (2008) · Hepatology International · doi:10.1007/s12072-008-9058-1 · Cited by 78
LESMANA, C. R. A., HASAN, I., BUDIHUSODO, U., GANI, R. A., KRISNUHONI, E., AKBAR, N., & LESMANA, L. A. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00386.x · Cited by 76
Zhou, Y., Li, Y., Nie, Y., Yang, H., Qi, Z., Huang, J. V., Shi, S., Lai, X., & Huang, H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06144.x · Cited by 76
Birkenfeld, A. L., Lee, H., Majumdar, S. K., Jurczak, M. J., Camporez, J. P., Jornayvaz, F. R., Frederick, D. W., Guigni, B. A., Kahn, M., Zhang, D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228817 · Cited by 75
Self-citationSystemic Release of Interleukin–10 During Orthotopic Liver Transplantation
Moine, O. L., Marchhant, A., Durand, F., Ickx, B., Pradier, O., Belghiti, J., Abramowicz, D., Gelin, M., Goldman, M., & Deviere, J. M. (1994) · Hepatology · doi:10.1002/hep.1840200417 · Cited by 74
Balent, B., Goswami, G., Goodloe, G. W., Rogatsky, E., RAUTA, O., NEZAMI, R., Mints, L., Angeletti, R. H., & Stein, D. T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04313.x · Cited by 61
Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice
Nadler, S. T., Stoehr, J. P., Rabaglia, M. E., Schueler, K. L., Birnbaum, M. J., & Attie, A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1249 · Cited by 58
Meyer, S. G. E., & de GROOT, H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.002 · Cited by 42
Alfrey, E. J., Most, D., Wang, X., Lee, L. K., Holm, B., Krieger, N. R., Sibley, R. K., Huie, P., & Dafoe, D. C. (1995) · Surgery · doi:10.1016/s0039-6060(05)80351-4 · Cited by 38
Lucero, D., Zago, V., Lopez, G. I., Graffigna, M. N., Fainboim, H. A., Miksztowicz, V., Meroño, T., Belli, S., Levalle, O. A., Wikinski, R. L. W., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.025 · Cited by 38
Contributions of Limb Incoordination and Postural Control Deficits to Cerebellar Gait Ataxia
Morton, S. M., & Bastian, A. J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb07609.x · Cited by 20
Cited by
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453
Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases
Li, S., Hong, M., Tan, H.-Y., Wang, N., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4234061 · Cited by 368
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih, M., & Jornayvaz, F. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.018 · Cited by 330
Self-citation
Metadata
- Authors
- Asrih, M., & Jornayvaz, F. R.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2013-07-05
- Volume
- 218
- Issue
- 3
- Pages
- R25-R36
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2125718576
- Cited by
- 282
- References
- 117
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.